1613 related articles for article (PubMed ID: 25629415)
1. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415
[TBL] [Abstract][Full Text] [Related]
2. (11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Zhang S; Smailagic N; Hyde C; Noel-Storr AH; Takwoingi Y; McShane R; Feng J
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010386. PubMed ID: 25052054
[TBL] [Abstract][Full Text] [Related]
3. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012884. PubMed ID: 29164602
[TBL] [Abstract][Full Text] [Related]
4. 18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Bonfill Cosp X; Flicker L
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012216. PubMed ID: 29164603
[TBL] [Abstract][Full Text] [Related]
5. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Ritchie C; Smailagic N; Noel-Storr AH; Ukoumunne O; Ladds EC; Martin S
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010803. PubMed ID: 28328043
[TBL] [Abstract][Full Text] [Related]
6. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
7. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723
[TBL] [Abstract][Full Text] [Related]
8. 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012883. PubMed ID: 29164600
[TBL] [Abstract][Full Text] [Related]
9. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).
Arevalo-Rodriguez I; Smailagic N; Roqué I Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010783. PubMed ID: 25740785
[TBL] [Abstract][Full Text] [Related]
10. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
McCleery J; Morgan S; Bradley KM; Noel-Storr AH; Ansorge O; Hyde C
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010633. PubMed ID: 25632881
[TBL] [Abstract][Full Text] [Related]
11. Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI).
Arevalo-Rodriguez I; Smailagic N; Roqué-Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD010783. PubMed ID: 34313331
[TBL] [Abstract][Full Text] [Related]
12. Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.
Archer HA; Smailagic N; John C; Holmes RB; Takwoingi Y; Coulthard EJ; Cullum S
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD010896. PubMed ID: 26102272
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Montreal Cognitive Assessment for the diagnosis of Alzheimer's disease and other dementias.
Davis DH; Creavin ST; Yip JL; Noel-Storr AH; Brayne C; Cullum S
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010775. PubMed ID: 26513331
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment.
Zhang S; Han D; Tan X; Feng J; Guo Y; Ding Y
Int J Clin Pract; 2012 Feb; 66(2):185-98. PubMed ID: 22257044
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.
Smailagic N; Lafortune L; Kelly S; Hyde C; Brayne C
J Alzheimers Dis; 2018; 64(4):1175-1194. PubMed ID: 30010119
[TBL] [Abstract][Full Text] [Related]
17. Montreal Cognitive Assessment for the detection of dementia.
Davis DH; Creavin ST; Yip JL; Noel-Storr AH; Brayne C; Cullum S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD010775. PubMed ID: 34255351
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.
Dinnes J; Ferrante di Ruffano L; Takwoingi Y; Cheung ST; Nathan P; Matin RN; Chuchu N; Chan SA; Durack A; Bayliss SE; Gulati A; Patel L; Davenport C; Godfrey K; Subesinghe M; Traill Z; Deeks JJ; Williams HC;
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012806. PubMed ID: 31260100
[TBL] [Abstract][Full Text] [Related]
19. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
[TBL] [Abstract][Full Text] [Related]
20. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a secondary care setting.
Chan CC; Fage BA; Burton JK; Smailagic N; Gill SS; Herrmann N; Nikolaou V; Quinn TJ; Noel-Storr AH; Seitz DP
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011414. PubMed ID: 31521064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
